Low-dose naltrexone calms overactive T-cells, which helps in mast cell disorders and chronic inflammation. It's not a cancer cure, but it can support the immune system's ability to fight tumor cells.
Another area where the T cells need a calming down and regulation are in chronic inflammatory states. So mast cell activation syndrome, mast cell disorders, big place where we use low-dose naltrexone because a piece of the pathology there is T cell deregulation. Another place where T cell regulation is incredibly important is the crossover with the immune response in cancer. So low-dose naltrexone is not a primary cancer treatment, but it is a supportive treatment. To try and help the immune system deal with the cancer.
